1. A comprehensive evaluation of the therapeutic potential of silibinin: a ray of hope in cancer treatment
   Pantha Prodip Ray et al, 2024, Frontiers in Pharmacology CrossRef
2. Correspondence on ‘Role of AMPK/mTOR-independent autophagy in clear cell renal cell carcinoma’ by Radovanovic et al
   Shahrokh Lorzadeh et al, 2021, Journal of Investigative Medicine CrossRef
3. A review of the botany, phytochemistry, pharmacology, synthetic biology and comprehensive utilization of Silybum marianum
   Xiaozhuang Zhang et al, 2024, Frontiers in Pharmacology CrossRef
4. Silibinin: an inhibitor for a high-expressed BCL-2A1/BFL1 protein, linked with poor prognosis in breast cancer
   Shradheya R. R. Gupta et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
5. MFAP2 promotes the progression of oral squamous cell carcinoma by activating the Wnt/β-catenin signaling pathway through autophagy
   Hao Zhang et al, 2023, Acta Biochimica et Biophysica Sinica CrossRef
6. Silibinin reduces cell proliferation and migration via EMT pathway in TFK-1 cell line
   Merve Özel Yetkin et al, 2024, Turkish Journal of Biochemistry CrossRef
7. β-catenin inhibitors in cancer therapeutics: intricacies and way forward
   Arundhathi Dev et al, 2023, Bioengineered CrossRef
8. Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review
   Sajad Fakhri et al, 2024, Cancer and Metastasis Reviews CrossRef